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Abstract 
Emerging research suggests that preventative swallowing rehabilitation, undertaken pre- or 
during (chemo)radiotherapy ([C]RT), can significantly improve early swallowing outcomes 
for head and neck cancer (HNC) patients. However, these treatment protocols are highly 
variable. Determining specific physiological swallowing parameters which are most likely to 
be impacted post-(C)RT would assist in refining clear targets for preventative rehabilitation. 
Therefore, this systematic review (1) examined the frequency and prevalence of physiological 
swallowing deficits observed post-(C)RT for HNC, and (2) determined the patterns of 
prevalence of these key physiological deficits over time post-treatment.  Online databases 
were searched for relevant papers published between January 1998 and March 2013. In total, 
153 papers were identified and appraised for methodological quality and suitability based on 
exclusionary criteria. Ultimately, nineteen publications met the study’s  inclusion criteria. 
Collation of reported prevalence of physiological swallowing deficits revealed reduced 
laryngeal excursion, base of tongue (BOT) dysfunction, reduced pharyngeal contraction and 
impaired epiglottic movement as most frequently reported. BOT dysfunction and impaired 
epiglottic movement showed a collective prevalence of over 75% in the majority of patient 
cohorts, whilst reduced laryngeal elevation and pharyngeal contraction had a prevalence of 
over 50%. Sub-analysis suggested a trend that the prevalence of key deficits is dynamic 
although persistent over time. These findings can be used by clinicians to inform preventative 
intervention, and support the use of specific, evidence-based therapy tasks explicitly selected 
to target the highly prevalent deficits post-(C)RT for HNC. 
 
Key words: deglutition, deglutition disorders, head and neck neoplasms, swallow 
pathophysiology 
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Introduction 
Dysphagia is recognised as a common, multifactorial and debilitating sequela for patients 
undergoing definitive (chemo)radiotherapy ([31]RT) for head and neck cancer (HNC). Whilst 
acute toxicities, including oedema, mucositis, pain and altered/thickened salivary flow,  
impair the swallowing mechanism in the short-term [1-4], radiation-induced tissue fibrosis 
and chronic oxidative stress perpetuate impairment to the deglutition musculature long after 
treatment has been completed [5-7]. These long-term swallowing complications can 
contribute to significant survivorship burden for HNC patients [8-10], resulting in detrimental 
impacts on psychosocial aspects of and participation in everyday life [11,12] and ultimately 
reduced quality of life [13,14].  
In light of the mounting evidence documenting the persistent and deleterious effects 
of (C)RT on the swallowing mechanism, optimal treatment methods for the management of 
dysphagia in this population have come into question. Historically, treatment approaches 
have been reactive, with rehabilitation administered after medical intervention (either surgical 
or non-surgical). However, emerging evidence [15-19] has instigated a shift towards the use 
of preventative dysphagia rehabilitation, based on the premise that proactively exercising 
swallowing structures known to be negatively impacted by radiation may limit the extent of 
(C)RT-induced dysfunction [20].  
A number of recent studies have reported the early benefits of preventative 
swallowing exercises for patients undergoing curative-intent (C)RT for HNC. In particular, 
the findings of three  RCTs [16,17,19] have demonstrated that patients who underwent 
prophylactic swallowing rehabilitation protocols pre- and/or during (C)RT had superior 
outcomes across a range of swallowing indexes following treatment, including: improved 
functional swallowing outcomes; significantly less deterioration in head and neck muscle 
composition; less decline in mouth opening, taste and smell; better preservation of salivary 
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flow; and fewer patients requiring or dependent on gastrostomy tube feeding.  However, 
despite each reporting some degree of positive findings for prophylactic swallowing exercises 
in the (C)RT-HNC population, examination of the study protocols reveals wide variability in 
the exercises employed, with each study reporting use of different groups of therapy tasks. In 
each, a range of between two and five therapy tasks have been implemented, which have 
included batteries of stretch and strengthening techniques including: tongue-base 
strengthening, range of motion and retraction exercises, Masako, effortful swallow, super-
supraglottic swallow and Mendelsohn manoeuvres, falsetto, jaw range of motion and jaw 
resistance training using the Therabite Jaw Rehabilitation System (Atos Medical AB, Hörby, 
Sweden) [16,17,19]. Great diversity in prophylactic exercise protocols has also been revealed 
in the clinical domain. Surveys of usual practice in HNC management have demonstrated that 
whilst there are a percentage of clinicians administering dysphagia therapy proactively 
[21,22], the nature of therapy provided is highly variable, with most survey respondents 
administering a range of exercises to address a range of potential swallowing impairments. 
This broad, non-specific approach is responsive to the lack of strong evidence for any one or 
particular set of manoeuver(s) to accomplish positive swallowing outcomes [21].  
In order to inform the formation of a core set swallowing exercises which may be 
most beneficial to apply proactively with HNC patients undergoing (C)RT, there is a need to 
clarify exactly (a) what are the predominant physiological changes to the swallowing 
mechanism associated with (C)RT treatment, (b) which of these changes occur with the 
highest prevalence, and (c) which remain long standing issues for patients in the months and 
years post treatment. Whilst a number of excellent systematic and critical reviews have 
already been published which discuss what is known about the characteristics of dysphagia 
following (C)RT for HNC and the clinical and functional implications for this population 
[3,12,23-27] no review to date has explicitly focused on the patterns of key physiologic or 
PHYSIOLOGICAL SWALLOWING DEFICITS FOLLOWING (C)RT FOR HNC 5 
 
anatomical disorders underlying these difficulties and compared their reported prevalence. 
Furthermore, no investigation has attempted to longitudinally analyse whether trends exist in 
the collective prevalence of swallowing impairments post-(C)RT. Therefore, the purpose of 
this systematic review is  to: (1) review the current evidence for the underlying physiological 
swallowing deficits observed post-(C)RT for HNC, in order to determine which deficits are 
highly frequent and prevalent, and (2) determine the patterns of prevalence of these key 
physiological deficits over time post-treatment.   
 
Method 
Search Strategy 
PubMed, Medline, ScienceDirect, SpringerLink, CINAHL and Wiley databases were 
searched for electronic publications in English published in peer-reviewed journals between 
January 1998 and March 2013. The following medical subject headings (MeSH) search terms 
were used: deglutition, deglutition disorders, radiotherapy, chemoradiotherapy and head and 
neck neoplasms. Additional search terms included head and neck cancer, dysphagia, 
swallowing, videofluroscopy and fiberoptic endoscopic evaluation of swallowing (FEES).  
Subsequently, the reference lists of identified studies and selected review papers were 
manually searched for additional relevant publications. 
Selection Criteria 
Studies were included if: 1) participants were adults diagnosed with HNC; 2) 
participants received (C)RT treatment regimens; and 3) objective dysphagia outcomes were 
reported utilising instrumental assessment (videofluroscopy or FEES) at one or more time 
points post-treatment. The following material was excluded: 1) review papers and editorials; 
2) studies reporting data pertaining to mixed cohorts (including primary surgical, post-
operative RT or recurrence populations); 3) studies only reporting dysphagia toxicity (i.e., 
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CTCAE or RTOG); 4) studies only utilising swallow assessments other than instrumental 
measures (i.e., swallowing-related or general quality of life, patient-reported swallowing 
function, dependence on alternative feeding); and 5) studies only reporting pre-treatment 
outcomes. Those publications reporting data exclusively on participants with nasopharyngeal 
carcinomas were also excluded, due to the disparities in pathology and treatment regimens 
that often accompany this population.      
In total, 153 papers were identified, 49 of which were deemed relevant after perusal of 
their abstracts (Figure 1). Three researchers reviewed these selected papers independently. 
Upon analysis of the full text, 29 studies were subsequently rejected, based on a second set of 
exclusionary criteria: 1) studies only reporting minimal or partial information relating to 
swallow physiology (i.e., penetration/aspiration, residue, stasis or oropharyngeal swallow 
efficiency only); 2) studies which collapsed instrumental swallow assessment results into a 
numeric scale and reported no descriptive physiological data; and 3) studies in which 
swallow physiology was not the primary outcome measure (including dosimetric analyses). 
This yielded a provisional cohort of 20 papers eligible for review [28-47]. Of these, two sets 
of articles by Cartmill et al. [29,30] and Kendall et al. [38,39] were identified as successive 
publications reporting data on the same respective groups of participants. To reduce this risk 
of publication bias, [29] was excluded in favour of the authors’ subsequent paper [30], which 
included a larger number of participants and thus demonstrated greater statistical power and 
methodological rigour. Conversely, the outcome measurements of the Kendall et al. 
studies[38,39] were deemed sufficiently different to warrant the inclusion of both papers, 
with the earlier research exclusively reporting structural physiological data (e.g., distance of 
hyoid displacement and degree of pharyngeal constriction), and the subsequent study 
focusing on temporal physiological measures (e.g., pharyngeal transit time and timing of 
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laryngeal vestibule closure). This left a total of 19 publications eligible for inclusion (Table 
1) [28,30-47].  
[Insert Figure 1 & Table 1 near here] 
Methodological Quality 
The methodological quality of eligible studies was also evaluated in detail, to 
determine their suitability for inclusion in the final analysis. As all publications were a 
variety of nonrandomised designs, this was performed using the Transparent Reporting of 
Evaluations with Nonrandomized Designs (TREND) checklist [48], developed to be 
consistent with the Consolidated Standards or Reporting Trials (CONSORT) statement for 
randomized controlled trials [49]. The 22 criteria specified by TREND were given a rating of 
1 (satisfies the criteria) or 0 (does not satisfy the criteria), yielding a possible total quality 
rating of 22. Three researchers rated the papers independently then subsequently met to 
compare their ratings and an agreed consensus was reached. A summary of the consensus 
TREND ratings for quality of methodology is shown as a modified harvest plot (Figure 2). 
This method was pioneered by Ogilvie et al. [50] and more recently utilised by Crowther et 
al. [51] to provide a visual display of synthesised evidence, where lack of homogeneity 
between studies has precluded the traditional use of a forest plot.  The average TREND score 
was 13.8 (range, 10–18). Despite the variable scorings, studies were deemed to have 
sufficiently comparable quality in their methodology and reported findings, hence none 
warranted exclusion from the final cohort.  
 [Insert Figure 2 near here] 
Data Synthesis 
 Sources of heterogeneity (population, treatment protocols, research design) in the 
studies included in this review prohibited a meta-analysis of the data. Therefore, the reported 
frequencies of physiological swallowing deficits (most commonly expressed as percentages) 
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are presented descriptively. The prevalence of aspiration, penetration, residue and stasis were 
also compiled due to their inextricable interactions with swallow physiology and frequent 
reporting in the literature. A second stage of sub-analyses explored the reported prevalence of 
these physiological and associated swallowing impairments over time. Percentage data was 
extracted from the papers which used specified evaluation points (i.e., baseline, 1-, 3-, 6-, and 
12-months post (C)RT). Those studies which only reported means [41], medians 
[28,34,35,37,47] or ranges [31,32] for follow-up assessments (Table 1) were excluded from 
this sub-analysis. The availability of comparable data points allowed longitudinal 
investigation up to 12 months post-(C)RT.   
 
Results 
Of the 19 publications that met the study criteria (Table 1), most were prospective 
studies (89%, n = 17) reporting on participant cohorts with heterogeneous disease sites (84%, 
n = 16), including the oral cavity, oropharynx, hypopharynx and larynx. Participants in the 
included studies underwent varied RT regimens of differing dose levels (mean 70.95Gy, 
range 65-79.2Gy), often accompanied by a range of concomitant chemotherapy agents 
(cisplatin, gemcitabine, carboplatin, paclitaxel, docetaxel, hydroxyurea and 5-fluorouracil). 
All publications used videofluroscopic swallow studies to evaluate patients’ physiological 
swallowing impairments. Almost half the studies (45%, n = 9) reported baseline data and the 
median follow-up assessment point was at 5.38 months (range: 1 month – 9 years) post-
treatment. Only four studies reported multiple post-treatment assessment points.    
Reported prevalence of physiological swallowing deficits 
The reported prevalence of physiological swallowing deficits observed post-(C)RT 
for HNC are summarised in Table 2. For those parameters with three or more studies 
reporting percentage data, overall prevalence ranges are provided. Abnormalities in the 
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pharyngeal phase predominated the data extracted from the reviewed papers. Dysfunction in 
the hyolaryngeal complex, namely reduced laryngeal elevation/excursion, was the most 
frequently reported physiological parameter, with 15 studies (79%) demonstrating deficits 
following (C)RT. An additional four studies reported deficits in hyoid movement.  Of those 
studies specifying percentages, 75% (n = 6/8) reported reduced laryngeal elevation to occur 
in more than 50% in their respective patient cohorts.  
Dysfunction in the base of tongue-posterior pharyngeal wall (BOT-PPW) complex 
was also frequently documented. Specifically, deficits relating to the BOT (i.e., BOT 
weakness, reduced BOT retraction, reduced BOT-PPW contact) were reported in 14 of the 19 
studies (74%). Reported percentages indicated high prevalence, with the majority recording 
BOT dysfunction in over 75% of patients. Three papers cited BOT weakness or reduced BOT 
retraction as the most [41,43] or one of the most [36] common swallowing abnormalities 
observed at all assessment intervals. Newman et al. [45] determined this parameter to be the 
most common across all bolus types. Absent or non-functional BOT retraction was reported 
in two studies. Correspondingly, reduced pharyngeal contraction and/or pharyngeal weakness 
was also reported with high frequency in the included studies (68%, n = 13). Where 
percentage data was specified, 75% (n = 6/8) of studies reported pharyngeal dysmotility to 
occur in more than 50% of patient cohorts. Two studies [40, 47] reported detailed analysis of 
pharyngeal constrictor dysmotility using Leopold and Kagel’s [52] videofluroscopic 
descriptors of pharyngeal transport abnormalities, whereby dysfunction to a specific 
pharyngeal constrictor is inferred from persistent residue on the appropriate segment of the 
posterior pharyngeal wall. This data revealed that the function of all three constrictor muscles 
deteriorated following (C)RT [40], however, the highest frequency of impairment was to the 
middle pharyngeal constrictor [47].  
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The next most frequently reported physiological swallowing deficit was again within 
the hyolaryngeal complex, with 10 studies documenting a reduction in epiglottic deflection 
following (C)RT. Of those studies specifying percentages, 89% (n = 8/9 studies) reported 
epiglottic dysfunction in more than 50% of patients, and over half (56%, n = 5/9) in over 75% 
of patients. Similar to BOT dysfunction, decreased epiglottic movement was cited by two 
studies as the most [34] or among the most prevalent pharyngeal phase abnormalities at all 
evaluation intervals [36]. Absent or non-functional epiglottic movement was reported in three 
papers and enlarged epiglottic structure by two papers. Impaired laryngeal vestibule closure 
was the final pharyngeal phase deficit of notable frequency, with seven studies (37%) 
reporting dysfunction in this parameter. However, the prevalence among patient cohorts was 
variable, ranging from <5% incomplete closure to 66% completely absent closure of the 
glottis following (C)RT.  
Compared with the pharyngeal phase, oral phase impairments were less frequently 
reported in the included literature. The most frequently reported oral phase parameter was 
reduced tongue strength and/or range of movement, documented in five studies. However, the 
prevalence was variable across papers, ranging from <5% - 60%. With regards to the upper 
esophageal phase, decreased opening of the UES was reported in six studies. However, it is 
unclear whether this frequency of UES dysfunction stemmed from core impairment to the 
cricopharyngeal muscle or as a comorbidity of reduced laryngeal movement, observed in 
many of the studies. The following physiological deficits had low prevalence in the literature, 
reported in less than 25% of the included studies: delayed triggering of the pharyngeal 
swallow (4 studies), premature spillage over the BOT (3 studies), velopharyngeal dysfunction 
(2 studies) and impaired mastication (1 study). 
[Insert Table 2 near here] 
Reported prevalence of penetration/aspiration, residue and stasis  
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The reported prevalence of penetration, aspiration, residue and stasis observed post-
(C)RT for HNC are summarised in Table 3. For those parameters with three or more studies 
reporting percentage data, overall prevalence ranges are provided. All but two papers [44,46] 
reported on penetration and/or aspiration allowing a total of 17 studies for analysis. Of these 
studies, 16 (94%) documented aspiration specifically and six (35%) documented penetration 
specifically, with one paper [32] presenting a combined penetration/aspiration finding. The 
prevalence of penetration and aspiration associated with (C)RT varied considerably among 
the included studies, ranging from 7-95.9% and 0-100% respectively. Four studies (21%) also 
documented cases of silent aspiration, the frequencies of which were also variable (range: 35-
86%). Pharyngeal residue was reported following (C)RT by 12 studies (63%). Of those 
specifying percentages, 89% (n = 8/9) observed residue in more than 50% of patients, and 
two-thirds (67%, n = 6/9) in over 75% of patients. Stasis in the pharynx was also reported in 
four studies, however the location of stasis and its prevalence was variable. 
[Insert Table 3 near here] 
Changes in prevalence of physiological swallowing deficits over time  
The literature pool contributing to the sub-analysis of physiological swallowing 
deficits over time consisted of: four studies reporting data pre-(C)RT [33,43,44,46], two 
studies  reporting at one month post-treatment [45,46], five studies at three months post-
treatment [33,42-44,46], two studies at six months post-treatment [30,46], and four studies at 
12 months post-treatment [38,39,44,46]. Percentages from applicable studies were collated 
and plotted to allow longitudinal examination from pre- to 12 months post-(C)RT. Graphical 
representations of the prevalence of aspiration and the most frequently reported oral phase 
(reduced tongue strength) and pharyngeal phase (reduced laryngeal elevation/excursion and 
reduced BOT retraction) deficits  are shown in Figures 3a-d.  These figures are demonstrative 
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of the general trends observed across all of the physiological and associated swallowing 
deficits documented in Tables 2 and 3.  
[Insert Figure 3 near here] 
 
Discussion 
The purpose of this systematic review was to coalesce the evidence for the frequency 
and prevalence of physiological swallowing deficits observed post-(C)RT for HNC. The most 
frequently reported physiological deficits were those to the hyolaryngeal and BOT-PPW 
complexes, including: reduced laryngeal excursion, BOT dysfunction, reduced pharyngeal 
contraction and impaired epiglottic movement. BOT dysfunction and impaired epiglottic 
movement exhibited a collective prevalence of over 75% in the majority of applicable patient 
cohorts, whilst reduced laryngeal elevation and pharyngeal contraction had a prevalence of 
over 50% in the majority of applicable cohorts.  
Dosimetric response studies are a new avenue of research seeking to ascertain how 
physiological swallowing parameters are differentially affected by (C)RT. Eisbruch et al. [32] 
were the first to postulate a set of dysphagia/aspiration-related structures (DARS) – 
deglutitive structures whose damage was deemed likely to cause dysphagia and aspiration, as 
observed on videofluroscopy, and demonstrated radiation-induced structural changes in post-
treatment CT scans. Recent review papers have reported these DARS to include the: superior, 
middle and inferior pharyngeal constrictors, glottic and supraglottic larynx and its adductor 
muscles, upper esophageal sphincter and mucosal/submucosal surfaces of the BOT [53,54]. 
Examination of dose-volume correlates for the DARS [54] have also revealed that the mean 
dose to the pharyngeal constrictor muscles was the most important dosimetric predictor of 
late swallowing complications (>3 months post-(C)RT). Whilst the notion of the general 
resistance of skeletal muscle to RT is well-accepted [55], it has been postulated that the 
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pharyngeal constrictor and laryngeal adductor muscles and epiglottic walls, which are 
situated in close proximity to the submucosa, may be secondarily affected by the acute 
radiation-induced inflammatory response of these mucosal layers, culminating in the loss of 
elasticity and therefore dysfunction of the laryngeal and oropharyngeal musculature [32,56]. 
Further research is still required to ratify the relationship between these anatomical changes 
and functional impacts on the swallowing mechanism, however these findings may explain 
why deficits in the BOT-PPW and hyolaryngeal complexes demonstrated the highest reported 
frequencies and prevalence in this review. Whilst abnormalities in the pharyngeal phase were 
the most prominent, the current review still observed deterioration across a myriad of 
physiological parameters, including those in the oral and upper esophageal phases. This 
appears to reflect the impact of large treatment fields required for definitive (C)RT in HNC 
patients, with similar oral and pharyngeal deglutitive structures targeted irrespective of lesion 
site to ensure adequate coverage of macroscopic disease [29,43,57,58]. The small proportion 
of oral cavity primary sites in the included studies may also have contributed to the 
comparatively low prevalence of oral-phase physiological deficits, relative to the pharyngeal 
phase.     
Exploratory sub-analysis demonstrated the collective prevalence of physiological 
swallowing deficits following (C)RT is dynamic over time post-treatment. This finding is not 
unexpected, as clinical manifestations of radiation-induced side-effects at different points 
along the treatment continuum are well differentiated in the literature [3]. Overall, the general 
trends observed across the physiological and associated deficits indicated a degree of 
impairment at baseline, deterioration of function following (C)RT peaking at 3-6 months 
post-treatment, and some degree of improvement in function 6-12 months post-treatment. 
However, the nature and extent of this amelioration in function in the later months post-
treatment is inconsistent across the parameters examined, as discussed further below.     
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Whilst aspiration (Fig 3a) exhibited the most bell-shaped distribution, with prevalence 
peaking at three months post-(C)RT, Figures 3b and 3c demonstrated ongoing deficits in the 
pharyngeal phase post-(C)RT, with function not improving in comparable magnitude by 12 
months post-treatment. Similarly, in the oral phase (Fig 3d), the prevalence of reduced tongue 
strength remained fundamentally static across the 12 months post-(C)RT. This is consistent 
with research findings which establish that although acute radiation-induced toxicities 
improve substantially in the months following (C)RT in the majority of patients, chronic 
fibrosis, neuropathy and atrophy of the oral, pharyngeal and laryngeal musculature endures 
long after the completion of treatment [37,47,59,60]. Thus, persisting impairment to the range 
of motion of the BOT-PPW and hyolaryngeal complex and muscle power of the tongue up to 
12 months post-(C)RT is indicative of these chronic sequelae. It has also been postulated that 
these ongoing oral and pharyngeal phase deficits may be attributable to consequential late 
reactions, phenomena caused by unhealed acute responses, which allow for additional 
mechanical or chemical damage distinct from true generic chronic impairments [61,62].  
The fact that the prevalence of aspiration improved despite these ongoing deficits also 
suggests that the irradiated swallowing mechanism may, in some capacity, physiologically 
adapt over time to improve swallow safety. Whether this is by means of conscious changes 
orchestrated by the patient, with or without assistance from post-(C)RT dysphagia 
rehabilitation, or by progressive unconscious changes to the underlying physiology of the 
involved structures is difficult to extrapolate. It should be noted that this improvement was 
based on the results of one study, and therefore requires further research to corroborate these 
findings. Nevertheless, the fact that the most prevalent physiological swallowing deficits (that 
of hyolaryngeal and BOT-PPW complexes) continued to remain highly prevalent up to 12 
months post-(C)RT confirms the need for ongoing rehabilitation of these parameters well in 
to the survivorship phase.      
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With the clinical use of prophylactic swallowing intervention still at a relatively 
nascent stage of implementation, the current investigation helps to refine which deficits may 
be best targeted in preventative exercise protocols. UK clinicians surveyed by Roe et al. [22] 
were reported to most commonly target: oral tongue range of motion (ROM), resistance and 
strength, hyolaryngeal movement, UES opening, BOT ROM and strength (using the effortful 
swallow and gargle techniques) and pharyngeal contraction (using the Masako manoeuvre). 
Less common prophylactic treatment foci included neck stretching, ROM exercises for the 
facial muscles, lips and jaw, and the super supraglottic swallow manoeuvre. In the USA, 
clinicians’ dysphagia intervention strategies during (C)RT included (in decreasing order of 
frequency): compensatory techniques, non-swallow exercises (BOT, laryngeal and 
pharyngeal exercises, Shaker manoeuvre), swallow manoeuvre exercises (Mendelsohn, 
effortful swallow and super supraglottic swallow), stretches (neck, jaw, tongue) or other 
therapies [21]. Therefore, research examining practice patterns for the management of the 
HNC-(C)RT population suggests that clinicians are targeting the most prevalent 
physiological deficits identified in this review, however they are also targeting a number of 
ancillary deficits and utilising a myriad of treatment strategies to rehabilitate them.        
This current multiplicity of exercises, in conjunction with the already intensive nature 
of researched prophylactic protocols, raises concerns regarding the clinical feasibility of, and 
patient adherence to, preventative dysphagia therapy in the (C)RT-HNC population. In order 
to contest such concerns, current exercise protocols need to be optimised. This requires the 
derivation and prioritisation of a core set of swallowing therapy targets, thus providing the 
precursor for consistent implementation into mainstream clinical practice. The authors 
acknowledge the importance of individualising treatment programs to achieve maximum 
functional and salient outcomes for patients. However, the findings of this review provide a 
preliminary set of core physiological swallowing parameters which are likely to become 
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particular sources of deficit for this population, based on their documented prevalence over 
time post-treatment. Further research is subsequently required to validate the impact of such 
core therapy targets on long-term patient outcomes.   
Whilst this was the first study to specifically elucidate the collective prevalence and 
patterns of physiological swallowing deficits following (C)RT for HNC, limitations are 
recognised. Firstly, the heterogeneity of the study cohort limited detailed inferential analysis 
in this review. There was considerable methodological variance in the number and types of 
physiological parameters assessed under videofluroscopy, which created the potential for 
bias. It is acknowledged that the reported frequency of a particular deficit may have been 
influenced by how common the deficit featured in the studies’ outcome measurements. 
Secondly, there was an absence of comprehensive reporting of physiological changes to the 
swallowing mechanism over multiple time-points, with only four studies achieving this. 
Consequently, the percentage data extracted for the exploratory longitudinal analysis was 
sporadic and the findings should therefore only be considered preliminary at this stage.  More 
systematic, longitudinal following and recording of physiological swallowing parameters in 
HNC patients is needed to allow better understanding of the trends dictating prevalence over 
time.  
 
Conclusion 
This is the first investigation to systematically review the frequency and prevalence of 
physiological swallowing deficits following (C)RT for HNC and analyse the prevalence 
patterns of these deficits over time. Collective analysis has demonstrated that reduced 
laryngeal excursion, BOT dysfunction, reduced pharyngeal contraction and impaired 
epiglottic movement are the most frequently reported and prevalent physiological swallowing 
deficits exhibited by HNC patients following (C)RT. Preliminary evidence suggests that the 
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prevalence of key deficits is dynamic though persistent over time. The current findings can be 
used to inform preventative intervention by identifying key, persistent deficits which are 
highly prevalent for HNC patients. This data is however only one part to the bigger question 
regarding prophylactic swallowing therapy. Ultimately, to fully understand (1) what 
parameters of the swallowing mechanism need to be targeted, (2) when is the optimal time to 
target these parameters, and (3) what are the most effective therapy tasks and methods of 
service delivery to habilitate them, ongoing research is required to validate and progress the 
results of the current study to optimise preventative swallowing exercise protocols in the 
future.        
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Table 1 
Studies included for review detailing study design, the number of participants, site of disease, treatment regimens and swallow physiology evaluation 
method.   
First Author Year Study design* N^ Site of disease Treatment Ax time point(s)  Formal outcome 
measure (if applicable) 
Bleier [28] 2007 Retrospective case series 49 Mixed (>2 sites) conRTa: 45 
IMRTb: 4 
CCTc: 36 
22.7 months#  
Cartmill [30] 2012 Prospective cohort study 31 Oropharynx  AFRT-CBd: 14 
CRTf: 17 
6 months NZIMESe 
PASg 
Eisbruch [31] 2002 Descriptive case series: 
post-test 
26 Mixed (>2 sites) CRT Pre-Tx 
1-3 months 
6-12 months 
 
Eisbruch [32] 2004 Prospective cohort study 26 Mixed (>2 sites) IMRT: 20 
RADPLATh: 6 
Pre-Tx 
1-3 months 
6-12 months 
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Feng [33] 2007 Descriptive case series: 
pre-test/post-test 
36 Oropharynx 
Nasopharynx 
CRT Pre-Tx 
3 months 
 
Goguen [34] 2006 Descriptive case series: 
post-test 
23 Mixed (>2 sites) CRT 3.5 months# Swallow Performance 
Scale 
Graner [35] 2003 Descriptive case series: 
pre-test/post-test 
11 Mixed (>2 sites) accRTi + CCT 19 weeks#  
Hutcheson 
[36] 
2008 Retrospective case series 32 Larynx conRT: 16 
accRT: 24 
IMRT: 3 
CCT: 30 
<6 months or 
6-11 months or 
12+ months 
 
Hutcheson 
[37] 
2012 Descriptive case series: 
post-test 
29 Mixed (>2 sites) RTj: 11 
CRT: 18 
9 years# PAS 
NIH-SSSk 
MBSImpl 
Kendall [38] 1998 Prospective cohort study 20 + 60 
controls 
Mixed (>2 sites) NR 12+ months  
Kendall [39] 2000 Prospective cohort study 20 + 60 
controls 
Mixed (>2 sites) conRT 12 months  
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Kotz [40] 1999 Descriptive case series: 
post-test 
15 Mixed (>2 sites) accRT + CCT 3-45 weeks  
Kotz [41] 2004 Descriptive case series: 
pre-test/post-test 
12 Mixed (>2 sites) CRT: 7 
accRT + CTT: 5 
Pre-Tx 
8 weeks$ 
 
Lal [42] 2009 Descriptive case series: 
post-test 
56 Mixed (>2 sites) accRT + CCT 3 months  
Logemann 
[43] 
2006 Prospective cohort study 53+140 
controls 
Mixed (>2 sites) CRT Pre-Tx 
3 months 
 
Logemann 
[44] 
2007 Prospective case series 48 Mixed (>2 sites) RT: 12 
CRT: 36 
Pre-Tx 
3 months 
12 months 
 
Newman [45] 2002 Prospective cohort study 30 Mixed (>2 sites) RADPLAT: 14 
CRT: 16 
Pre-Tx 
1 month 
 
Pauloski [46] 2006 Prospective case series 170 Mixed (>2 sites) RT: 22 
CRT: 147 
Pre-Tx 
1, 3, 6 and 12 
months 
 
Smith [47] 2000 Prospective case series 10 Mixed (>2 sites) CRT 9 weeks#  
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70 weeks# 
aconventional radiotherapy; bintensity modulated radiotherapy; cconcomitant chemotherapy; daltered fractionation radiotherapy with concomitant boost; 
eNew Zealand Index for Multidisciplinary Evaluation of Swallowing; fchemoradiotherapy; gPenetration Aspiration Scale; hradiotherapy and 
concomitant intra-arterial cisplatin; iaccelerated radiotherapy; jradiotherapy alone; kNational Institutes of Health Swallowing Safety Scale; lMBSImp = 
MBS impairment profile 
*Based on the NHMRC Guidelines (NHMRC, 2000; 2005) 
^
 Refers to number of participants who underwent at least one instrumental swallow assessment  
#
 denotes median follow-up point  
$
 denotes mean follow-up point  
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Table 2:  
Reported prevalence of physiological swallowing deficits in papers included for review.  
Deficit Reported Prevalence in Reviewed Papers 
ORAL PHASE 
  
Impaired mastication  50% or more[30] 
  
Overall Prevalence Range: <5% - 60%  
 57 - 60%[44]* 
 51% reduced strength; <5%: reduced       
 
 lateral/anterior stabilisation and vertical 
movement[43] 
 
 11%[42] 
 
 
Reduced tongue 
strength/movement 
 
 Reported, but no percentage data provided[45], [46] 
PHARYNGEAL PHASE 
 14% palatal kink; 12.5% loss of nasopharyngeal     
 
 seal[42] 
 
Impaired Velopharyngeal 
closure  
 <5%[43] 
 BOT-PPW Complex   
  
Overall Prevalence Range: 26.5% - 36%  
 
 36%[42] 
 
 >30%[30] 
 
 
Premature spill 
 26.5%[28] 
  
Overall Prevalence Range: 55% - 100%  
 
 100% abnormal retraction, 17% absent[37]  
 
 89% reduced function, 3% non-functional[33]  
 
 
BOT weakness/ reduced 
BOT retraction 
 89%[43] 
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85 - 100%[32] 
 
 85 - 90%[44] 
 
 84.7 - 94%[46]  
 
 82%[35] 
 
 80 – 100%[36] 
 
 55 - 85%[31] 
 
 Reported, but no percentage data provided [38], [45] 
 
 100%[41] 
 
 
Reduced BOT-PPW contact 
 Reported, but no percentage data provided [34] 
  
Overall Prevalence Range: 21% - 100% 
 
 100%[32]  
 
 100% abnormal, 34% absent[37] 
 
 80% [40]  
 
 79.6%[28] 
 
 60 – 100%[47]  
 
 50% or more[30] 
 
 
 
29% unilateral impairment[42]  
21 - 23%[44] 
 Reported, but no percentage data provided[38], [39],  
 
 
Reduced pharyngeal 
contraction/ pharyngeal 
weakness/  
 
[41], [43], [45]
 
 Hyolaryngeal Complex  
  
Overall Prevalence Range: 46% - 100%  
 
 100% abnormal, 86% absent[37] 
 
 100%; 93% enlarged epiglottis[40] 
 
 100% abnormal or absent[47] 
 
 
Impaired epiglottic inversion 
 
 
 
 86.7 – 100%[36]  
PHYSIOLOGICAL SWALLOWING DEFICITS FOLLOWING (C)RT FOR HNC 34 
 
 
 85.7%; 57.1% bulbous epiglottis[28] 
 
 61% reduced function, 22% non-functional[33] 
 
 50 – 54%[31] 
 
 50 - 83%[32] 
 
 46%[42] 
 
 Reported, but no percentage data provided [34], [41] 
  
Overall Prevalence Range: 31% - 100%  
 
 100% abnormal, 17% absent[37] 
 
 82%[35]  
 
 78.3 - 85.7%[36]  
 
 67%[33] 
 
 50 - 83%[32]  
 
 50% or more[30] 
36%[43] 
 
 
Reduced laryngeal 
elevation/excursion 
 
 31 - 35%[44]  
 Reported, but no percentage data provided [34], [38],  
  
 
 
[40], [41],  [45], [46], [47]
 
 
 97% abnormal, 38% absent[37] 
 
 41%[42] 
 
 
Reduced hyoid movement  
 Reported, but no percentage data provided [38], [39] 
 
Overall Prevalence Range: <5% - 83% 
 
 50 - 83%[32] 
 
 66% absent closure[37]  
54 - 60%[44] 
 
 
 31% slowed/delayed, <5% incomplete closure[43]  
 
Impaired Laryngeal Vestibule 
closure 
 Reported, but no percentage data provided [39], [41],  
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[45], [46]
 
 42 - 56%[44] 
 
 30 - 62%[31] 
 
Delayed swallow reflex 
 Reported, but no percentage data provided [45], [46] 
OESOPHAGEAL PHASE 
 
Overall Prevalence Range: 17% - 100% 
 
 100%[32] 
 
 50% or more[30] 
 
 28.3%[43] 
 
 21 - 23%[44] 
 
 17%[41] 
 
Decreased opening of UES 
 Reported, but no percentage data provided [46] 
*Data reported for multiple time points, bolus types or treatment groups are indicated as ranges
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Table 3:  
Reported prevalence of penetration, aspiration, residue and stasis in papers included for review. 
Deficit Reported Prevalence in Reviewed Papers 
Overall Prevalence Range: 7% - 95.9% 
 95.9%[28] 
 82%[35] 
 67%[40]  
 17%[34] 
 7 - 35%[30]* 
Penetration 
 Reported, but no percentage data provided[41] 
Overall Prevalence Range: 0% - 100% 
 100%, 82% silent[37] 
 78%, 35% silent[34]  
 73.3 – 85.7%, 44% silent[36] 
 68%[31] 
 65.3%[28]  
 64%, 86% silent[35]  
 52%[42] 
 44%[33] 
 40%[47] 
 33%[41] 
 23%[43] 
 10%[38] 
 10%[39] 
 7 – 41%[30]  
Aspiration 
 0 – 40%[45] 
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 Reported, but no percentage data provided [40] 
Combined P/A reporting   60 – 100%[32]  
Overall Prevalence Range: 33% - 100% 
 100%[37] 
 94%[33] 
 90%[35] 
 80%[40] 
 75 - 100%[32] 
 75 - 77%[31] 
 70 - 88% vallecular residue; 38 - 50% pyriform residue[47] 
 54%[42] 
 33%[41]  
Pharyngeal Residue  
 Reported, but no percentage data provided [39], [43], [45] 
 80 - 100% pharyngeal stasis[47]  
 80% supraglottic laryngeal and pharyngeal stasis[40] 
 57.1% pyriform stasis[28] 
Stasis  
 45% vallecular stasis; 19% pyriform stasis[33] 
*Data reported for multiple time points, bolus types or treatment groups are indicated as ranges
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Figure 1 
PRISMA Flow Diagram detailing search strategy and selection criteria.  
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Records excluded  
(n = 104) 
• Reviews/editorials (25) 
• Mixed cohorts (28) 
• Toxicity only (21) 
• Other non-instrumental Ax (19) 
• Pre-Tx only (6) 
• NPC only (5) 
Records screened  
(n = 153) 
Full-text articles assessed 
for eligibility  
(n = 49) 
Methodological quality 
analysis 
0 papers excluded 
Studies included in review  
(n = 19) 
Full-text articles excluded  
(n = 30) 
• Minimal/partial swallow 
physiology (13) 
• Data only reported as numeric 
scale (4) 
• Physiology not primary outcome 
measure (12) 
• Multiple reporting on same 
patient cohort (1) 
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Figure 2  
Harvest plot of consensus ratings given for each included study reviewed using the TREND 
checklist. 
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Figures 3a – d 
Reported prevalence of aspiration and core oral and pharyngeal phase physiological 
swallowing deficits at varying follow-up points over time.    
Fig 3a                                                                           Fig 3b 
 
 
Fig 3c                                                                       Fig 3d 
 
 
 
